Asia-Pacific Americas Africa Europe Middle East

Пред во SANDOZ PHARMACEUTICALS в РУ

Company Profile:



Nature of Business: Trading Company / Representative Office

Company Introduction:

Sandoz is a global leader in generic and biosimilar medicines, and a division of the Novartis Group. Its presence in the Republic of Uzbekistan primarily functions as a representative office, focusing on the sales, marketing, and distribution of its pharmaceutical products within the country. It is not a manufacturing facility or factory in Uzbekistan, but rather an entity responsible for market access, commercial activities, and establishing its brand presence for the import and sale of its global product portfolio.

Enterprise Products

SANDOZ PHARMACEUTICALS in Uzbekistan, through its representative office, typically offers a wide range of generic and biosimilar medicines across various therapeutic areas. A comprehensive, real-time list of every single product manufactured or sold by a specific representative office is dynamic and often not publicly consolidated. However, their product portfolio generally includes medicines in the following categories:

Cardiovascular medicines

Anti-infectives

Central nervous system drugs

Oncology products

Respiratory treatments

Gastrointestinal medications

Dermatological preparations

Pain management drugs

Biosimilars (generic versions of complex biological medicines)

Metabolic disorder treatments

Urological preparations

These categories encompass a vast array of pharmaceuticals, including antibiotics, analgesics, hypertension medications, diabetes treatments, and various other essential medicines.

Business Registration Information:

Manager:

No Data

Phone:

+998 71 232 02 02

E-mail:

No Data

Official Website:
Address:

Business Center "Poytaht", Amir Temur Street, 107B, Tashkent, 100084, Uzbekistan

This content is from AI, the data and information provided is for reference only and is not applicable to investment and purchase decisions. If there is any incorrect information, please contact customer service to correct it.